Nutraplus India: A Deep Dive into Q2 FY26 Results and Auditor's Alarming Findings
Nutraplus India Limited has unveiled its unaudited standalone financial results for the quarter ended September 30, 2025 (Q2 FY26), revealing a deeply concerning financial trajectory marked by declining revenues, widening losses, and severe compliance issues flagged by its auditors.
The Numbers: Deteriorating Performance
For Q2 FY26, the company reported Revenue from Operations of ₹0.98 Cr, a notable decrease from ₹1.17 Cr in the same quarter last year (Q2 FY25). Total Income mirrored this trend, falling to ₹0.98 Cr from ₹1.17 Cr YoY. The most alarming figure is the Net Loss, which ballooned to ₹2.09 Cr in Q2 FY26, a significant escalation from a ₹0.04 Cr loss in Q2 FY25. Consequently, Earnings Per Share (EPS) stands at ₹-0.11 (Basic & Diluted).
The trend is consistent for the half-year ended September 30, 2025 (YTD FY26). Revenue from Operations declined to ₹1.96 Cr from ₹2.48 Cr in YTD FY25, while the Net Loss widened substantially to ₹2.05 Cr, compared to ₹0.65 Cr in the prior year.
The Auditor's Verdict: A Critical "Grill"
Adding a grave layer to these disappointing numbers is the issuance of a Qualified Limited Review Report by auditors Raman S. Shah & Associates. The report highlights significant non-compliance by Nutraplus India with listing requirements, including the timely submission of its limited review report and quarterly results. Auditors explicitly stated that the company failed to provide necessary financial data in a timely manner, which "significantly impaired" their ability to conduct a comprehensive review.
A particularly severe disclosure (Note 5) reveals that Nutraplus India lost all its property, plant, and equipment under the SARFEASI Act, 2002. This drastic measure followed the company being declared a Non-Performing Asset (NPA) in FY19-20. While the auction was delayed due to the COVID-19 pandemic, the outcome points to a catastrophic loss of operational assets.
Financial Health: A Bleak Balance Sheet
As of September 30, 2025, the company's financial position is dire. Total Assets stand at ₹499.76 Cr, but Total Equity is a severely negative ₹-571.52 Cr, indicating technical insolvency. The debt burden is astronomical, with Total Borrowings (Non-Current + Current) amounting to a staggering ₹1017.87 Cr. With Cash and Cash Equivalents at a mere ₹0.02 Cr, the Net Debt position is approximately ₹1017.85 Cr. The current ratio, estimated at around 0.046, underscores an extreme liquidity crunch and inability to meet short-term obligations.
Risks & Outlook
Nutraplus India faces immense risks, including potential regulatory action from SEBI and stock exchanges due to non-compliance, the ongoing inability to conduct a thorough audit, and the fundamental challenge of operating without its core property, plant, and equipment. The company has provided no forward-looking statements, guidance, or management commentary on future prospects, leaving investors with no visibility into any potential turnaround strategy or operational recovery. The extremely high debt and negative equity paint a picture of a company in deep financial distress, making its equity highly speculative.